Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Vitamin D synthesis reduced following burn injuries

Feb. 23, 2004

Promising results found with topical doxycycline for chronic diabetic ulcers

Feb. 18, 2004

First phase of Dermicol testing completed

Feb. 16, 2004

Melanotan implant study produces encouraging results

Feb. 16, 2004

Efficacy and safety of efalizumab in the treatment of psoriasis

Feb. 13, 2004

Connetics to acquire Soriatane

Feb. 12, 2004

Preliminary results of adalimumab in the treatment of chronic plaque psoriasis

Feb. 12, 2004

Clinical, other studies of pimecrolimus presented at dermatology congress

Feb. 11, 2004

Use of infliximab in the treatment of psoriasis, dermatitis, other conditions reported at AAD

Feb. 11, 2004

Studies demonstrate efficacy of Tri-Luma in melasma patients

Feb. 11, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.